1215034

Granules Pharmaceuticals Inc. — FEI 3011585184

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 3, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Chantilly, VA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)